详情页 - 聚合机构库演示平台

当前位置：首页 > 详情页

Targeted Drug Combined With CHOP in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma

64| 认领 | 链接全文 |

文献详情

编号/登记号：

注册时间：

研究开始时间：

研究结束时间：

项目类型：

本院角色：

多中心研究：

招募状态：

试验分期：

研究疾病/适应症：

研究类型：

研究负责人：

研究单位： [1]Ruijin Hospital [2]Department of Hematology, Peking University Third Hospital, Beijing, China,Beijing,China [3]Department of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan, China,Chengdu,China [4]Department of Hematology, Fujian Institute of Hematology, Fujian Provincial Key Laboratory on Hematology, Union Hospital, Fujian Institute of Hematology, Fuzhou, China,Fuzhou,China [5]Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China,Shandong,China [6]Shanghai Ruijin Hospital,Shanghai,China [7]Department of Hematology,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan,China,Wuhan,China [8]Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China,Wuhan,China

关键词： Peripheral T-cell lymphoma Targeted therapy

研究目的：

This prospective，multi-center，open-label, controlled study will evaluate the efficacy and safety of targeted drug in combination with CHOP in treatment of newly diagnosed peripheral T-cell lymphoma.